Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT 4:00:00 PM EDT
| Market Cap (Intraday) | 351.77M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $13.10 |
| 50-Day MA | $12.43 |
| 200-Day MA | $15.90 |
Arcturus Therapeutics Holdings Inc Stock, NASDAQ:ARCT
10628 Science Center Drive, Suite 250, San Diego, California 92121
United States of America
Phone: +1.858.900.2660
Number of Employees: 176
Description
Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.